← Leaderboards
Alan Thomas Johnson
Hawaii Biotech, Inc.
$20,896,391
Attributed
$20,896,391
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.5M · FY2005–24$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$20,896,391 · 7
By mechanism
R01$8,052,445 · 1
R44$6,044,471 · 1
U01$5,302,002 · 1
R43$1,495,884 · 3
P41$1,589 · 1
Top collaborators
No co-investigators on record.
Most similar at Hawaii Biotech, Inc.
Same institution · by research overlap
- Sherri Zimmerman Millis$1,290,247
- David Clements$2,997,218
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsCellsVaccinesCessation Of LifeLeadBacteriaInhibitor/AntagonistDesignSafetyAnthrax Lethal FactorSmall MoleculeCostDoseToxic EffectLeftEventInfectionEnsureAntibioticsBacillus Anthracis SporeIntoxicationBacillus AnthracisIn VivoAnthrax Disease
Grant awards (24)
Novel TLR-4 Agonists as Vaccine Adjuvants$204,860
R43 · FY2024 · AI · contact PI
Novel TLR-4 Agonists as Vaccine Adjuvants$203,485
R43 · FY2023 · AI · contact PI
IND Enabling Studies for Small Molecule Anthrax Lethal Factor Inhibitors$1,600,303
R01 · FY2017 · AI · contact PI
IND Enabling Studies for Small Molecule Anthrax Lethal Factor Inhibitors$1,569,436
R01 · FY2016 · AI · contact PI
IND Enabling Studies for Small Molecule Anthrax Lethal Factor Inhibitors$1,593,546
R01 · FY2015 · AI · contact PI
IND Enabling Studies for Small Molecule Anthrax Lethal Factor Inhibitors$1,528,431
R01 · FY2014 · AI · contact PI
IND Enabling Studies for Small Molecule Anthrax Lethal Factor Inhibitors$1,126,264
R01 · FY2013 · AI · contact PI
IND Enabling Studies for Small Molecule Anthrax Lethal Factor Inhibitors$634,465
R01 · FY2013 · AI · contact PI
Antidotes to Anthrax Lethal Factor Intoxication$1,140,279
U01 · FY2012 · AI · contact PI
Antidotes to Anthrax Lethal Factor Intoxication$1,206,265
U01 · FY2011 · AI · contact PI
Antidotes to Anthrax Lethal Factor Intoxication$1,057,909
U01 · FY2010 · AI · contact PI
Antidotes to Anthrax Lethal Factor Intoxication$1,067,549
U01 · FY2009 · AI · contact PI
Inhibitors of Anthrax Lethal Factor Metalloproteinase$891,165
R44 · FY2009 · AI · contact PI
Discovery of Broad Spectrum Dengue Virus Proteinase Inhibitors$299,960
R43 · FY2009 · AI · contact PI
Inhibitors of Anthrax Lethal Factor Metalloproteinase$191,700
R44 · FY2009 · AI · contact PI
Inhibitors of Anthrax Lethal Factor Metalloproteinase$882,133
R44 · FY2008 · AI · contact PI
Antidotes to Anthrax Lethal Factor Intoxication$830,000
U01 · FY2008 · AI · contact PI
Discovery of Broad Spectrum Dengue Virus Proteinase Inhibitors$299,997
R43 · FY2008 · AI · contact PI
Inhibitors of Anthrax Lethal Factor Metalloproteinase$885,095
R44 · FY2007 · AI · contact PI
Discovery of West Nile Virus Protease Inhibitors$487,582
R43 · FY2007 · AI · contact PI
NANO-RULERS BASED ON SUPPORTED HYBRID LIPID BILAYERS$1,589
P41 · FY2007 · RR · contact PI
Inhibitors of Anthrax Lethal Factor Metalloproteinase$1,240,547
R44 · FY2006 · AI · contact PI
Inhibitors of Anthrax Lethal Factor Metalloproteinase$1
R44 · FY2006 · AI · contact PI
Inhibitors of Anthrax Lethal Factor Metalloproteinase$1,953,830
R44 · FY2005 · AI